심장 수술용 기구 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Cardiac Surgery Instruments Market Summary

The global cardiac surgery instruments market size was estimated at USD 2.80 billion in 2024 and is projected to reach USD 5.36 billion, growing at a CAGR of 7.56% from 2025 to 2033. Rising prevalence of cardiovascular diseases, increasing adoption of advanced surgical techniques, and growing demand for precision-driven procedures are expected to drive the cardiac surgery instruments market.

The shift toward minimally invasive surgeries, coupled with technological advancements that enhance safety and efficiency, is further anticipated to support market expansion. In August 2025, the European Journal of Preventive Cardiology reported that global CVD prevalence will rise 90% by 2050, with deaths increasing from 20.5 million in 2025 to 35.6 million, while age-standardized mortality is projected to fall 30.5%. The rising prevalence of cardiovascular diseases is a primary driver for the cardiac surgery instruments market, as these conditions remain the leading cause of mortality worldwide and frequently necessitate surgical intervention. With aging populations and growing incidence of lifestyle-related disorders such as obesity, hypertension, and diabetes, the number of patients requiring procedures like coronary artery bypass grafting and valve repair continues to rise. In July 2025 , the World Health Organization (WHO) reported that cardiovascular diseases caused 19.8 million deaths in 2022 (32% of all deaths), with 85% from heart attack and stroke, and over three-quarters occurring in low- and middle-income countries.

The increasing adoption of advanced surgical techniques, including minimally invasive and robotic-assisted procedures, is fueling the need for specialized instruments designed for precision and efficiency. Surgeons and hospitals are shifting away from traditional open-heart approaches toward less invasive methods that require advanced toolkits with ergonomic designs, durability, and compatibility with hybrid operating rooms. In July 2022, Netcare Christiaan Barnard Hospital in South Africa introduced the first robotic-assisted cardiothoracic surgery program in the region using the da Vinci system. These techniques improve surgical accuracy and reduce recovery times, making them highly preferred by both healthcare providers and patients, thereby accelerating the demand for next-generation cardiac surgery instruments.

Growing demand for precision-driven procedures also plays a significant role in market expansion, as cardiac surgeries require exactness where even the smallest errors can have life-threatening consequences. The push for accuracy has led to innovations in instrument design, with micro-instruments, enhanced forceps, and sharper cutting tools becoming essential in complex surgeries such as pediatric and valve procedures. In May 2025, an article in the Annals of Cardiothoracic Surgery highlighted the adoption of fully robotic lateral access aortic valve replacement (RAVR) as a key advancement in minimally invasive surgery. The procedure demands high-precision handling, making forceps integral for tissue manipulation and suturing in confined operative fields.

The growing prevalence of cardiovascular diseases, combined with the expansion of cardiac surgical procedures worldwide, is driving steady demand for advanced cardiac surgery instruments. Hospitals and surgical centers are increasingly investing in high-quality tools to improve patient outcomes, reduce procedure times, and support minimally invasive techniques, highlighting the critical role of reliable instruments in modern cardiac care. Rising awareness of cardiovascular health and increasing healthcare infrastructure in emerging markets are further boosting demand, while innovations in instrument design continue to enhance surgical precision and safety.

In June 2024, an article in Annals of Thoracic Surgery Short Reports highlighted that high-income countries perform an average of 123.2 cardiac surgeries per 100,000 population annually, while low- and middle-income countries perform 40-86 procedures per 100,000, reflecting a substantial global gap. With over 1 million cardiac surgeries worldwide each year, including CABG, valve, and congenital procedures, the study underscores the growing demand for cardiac surgery instruments to meet population needs. Expanding surgical capacity in LMICs could significantly increase procedure volumes, driving demand for specialized instruments.

Global Cardiac Surgery Instruments Market Report Segmentation

This report forecasts revenue and volume growth at global, regional, and country levels and analyzes industry trends in each sub-segments from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the global cardiac surgery instruments market report based on product, application, end use, and region:

• Product Outlook (Revenue USD Million, 2021 - 2033)
• Forceps
• Clamps
• Graspers
• Scissors
• Needle Holder
• Others
• Application Outlook (Revenue USD Million, 2021 - 2033)
• Coronary Artery Bypass Grafting
• Heart Valve Surgery
• Pediatric Cardiac Surgery
• Heart Transplant
• Others
• End Use Outlook (Revenue USD Million, 2021 - 2033)
• Hospitals
• Ambulatory Surgical Center
• Regional Outlook (Revenue USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Spain
  • Italy
  • France
  • Denmark
  • Norway
  • Sweden
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment scope
  • 1.1.2. Regional scope
  • 1.1.3. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
• 1.7. Research Assumptions
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Application outlook
  • 2.2.3. End Use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Cardiac Surgery Instruments Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising prevalence of cardiovascular diseases
    • 3.2.1.2. Growing demand for minimally invasive cardiac surgeries
    • 3.2.1.3. Technological advancements in surgical instruments
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of advanced cardiac surgery instruments
    • 3.2.2.2. Shortage of skilled cardiac surgeons
• 3.3. Cardiac Surgery Instruments: Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTLE Analysis
• 3.4. Regulatory Framework

Chapter 4. Cardiac Surgery Instruments Market Segment Analysis, By Product, 2021 - 2033 (USD Million)

• 4.1. Definition and Scope
• 4.2. Product Market Share Analysis, 2024 & 2033
• 4.3. Segment Dashboard
• 4.4. Global cardiac surgery instruments Market, by product, 2021 to 2033
• 4.5. Forceps
  • 4.5.1. Forceps market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.6. Clamps
  • 4.6.1. Clamps market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.7. Graspers
  • 4.7.1. Graspers market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.8. Scissors
  • 4.8.1. Scissors market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.9. Needle Holder
  • 4.9.1. Needle holder market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.10. Others
  • 4.10.1. Others market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. Cardiac Surgery Instruments Market Segment Analysis, By Application, 2021 - 2033 (USD Million)

• 5.1. Definition and Scope
• 5.2. Application Market Share Analysis, 2024 & 2033
• 5.3. Segment Dashboard
• 5.4. Global cardiac surgery instruments Market, by application, 2021 to 2033
• 5.5. Coronary Artery Bypass Grafting
  • 5.5.1. Coronary artery bypass grafting market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.6. Heart Valve Surgery
  • 5.6.1. Heart valve surgery market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.7. Pediatric Surgery
  • 5.7.1. Pediatric surgery market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.8. Heart Transplant
  • 5.8.1. Heart transplant market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.9. Others
  • 5.9.1. Others market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. Cardiac Surgery Instruments Market Segment Analysis, By End Use, 2021-2033 (USD Million)

• 6.1. Definition and Scope
• 6.2. End Use Market Share Analysis, 2024 & 2033
• 6.3. Segment Dashboard
• 6.4. Global cardiac surgery instruments Market, by end use, 2021 to 2033
• 6.5. Hospitals
  • 6.5.1. Hospitals market estimates and forecasts, 2021 to 2033 (USD million)
• 6.6. Ambulatory Surgical Centers (ASCs)
  • 6.6.1. Ambulatory surgical centers (ASCs) market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. Cardiac Surgery Instruments Market Segment Analysis, By Region, 2021 - 2033 (USD Million)

• 7.1. Regional Market Share Analysis, 2024 & 2033
• 7.2. Regional Market Dashboard
• 7.3. Regional Market Snapshot
• 7.4. Cardiac Surgery Instruments Market Share by Region, 2024 & 2033:
• 7.5. North America
  • 7.5.1. North America cardiac surgery instruments market, 2021 - 2033 (USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Regulatory Scenario
    • 7.5.2.3. Competitive Scenario
    • 7.5.2.4. U.S. cardiac surgery instruments market, 2021 - 2033 (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Regulatory Scenario
    • 7.5.3.3. Competitive Scenario
    • 7.5.3.4. Canada cardiac surgery instruments market, 2021 - 2033 (USD Million)
  • 7.5.4. Mexico
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Regulatory Scenario
    • 7.5.4.3. Competitive Scenario
    • 7.5.4.4. Mexico cardiac surgery instruments market, 2021 - 2033 (USD Million)
• 7.6. Europe
  • 7.6.1. Europe cardiac surgery instruments market, 2021 - 2033 (USD Million)
  • 7.6.2. UK
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Regulatory Scenario
    • 7.6.2.3. Competitive Scenario
    • 7.6.2.4. UK cardiac surgery instruments market, 2021 - 2033 (USD Million)
  • 7.6.3. Germany
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Regulatory Scenario
    • 7.6.3.3. Competitive Scenario
    • 7.6.3.4. Germany cardiac surgery instruments market, 2021 - 2033 (USD Million)
  • 7.6.4. France
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Regulatory Scenario
    • 7.6.4.3. Competitive Scenario
    • 7.6.4.4. France cardiac surgery instruments market, 2021 - 2033 (USD Million)
  • 7.6.5. Italy
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Regulatory Scenario
    • 7.6.5.3. Competitive Scenario
    • 7.6.5.4. Italy cardiac surgery instruments market, 2021 - 2033 (USD Million)
  • 7.6.6. Spain
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Regulatory Scenario
    • 7.6.6.3. Competitive Scenario
    • 7.6.6.4. Spain cardiac surgery instruments market, 2021 - 2033 (USD Million)
  • 7.6.7. Norway
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Regulatory Scenario
    • 7.6.7.3. Competitive Scenario
    • 7.6.7.4. Norway cardiac surgery instruments market, 2021 - 2033 (USD Million)
  • 7.6.8. Sweden
    • 7.6.8.1. Key Country Dynamics
    • 7.6.8.2. Regulatory Scenario
    • 7.6.8.3. Competitive Scenario
    • 7.6.8.4. Sweden cardiac surgery instruments market, 2021 - 2033 (USD Million)
  • 7.6.9. Denmark
    • 7.6.9.1. Key Country Dynamics
    • 7.6.9.2. Regulatory Scenario
    • 7.6.9.3. Competitive Scenario
    • 7.6.9.4. Denmark cardiac surgery instruments market, 2021 - 2033 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Japan
    • 7.7.1.1. Key Country Dynamics
    • 7.7.1.2. Regulatory Scenario
    • 7.7.1.3. Competitive Scenario
    • 7.7.1.4. Japan cardiac surgery instruments market, 2021 - 2033 (USD Million)
  • 7.7.2. China
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Regulatory Scenario
    • 7.7.2.3. Competitive Scenario
    • 7.7.2.4. China cardiac surgery instruments market, 2021 - 2033 (USD Million)
  • 7.7.3. India
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Regulatory Scenario
    • 7.7.3.3. Competitive Scenario
    • 7.7.3.4. India cardiac surgery instruments market, 2021 - 2033 (USD Million)
  • 7.7.4. Australia
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Regulatory Scenario
    • 7.7.4.3. Competitive Scenario
    • 7.7.4.4. Australia cardiac surgery instruments market, 2021 - 2033 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Regulatory Scenario
    • 7.7.5.3. Competitive Scenario
    • 7.7.5.4. South Korea cardiac surgery instruments market, 2021 - 2033 (USD Million)
  • 7.7.6. Thailand
    • 7.7.6.1. Key Country Dynamics
    • 7.7.6.2. Regulatory Scenario
    • 7.7.6.3. Competitive Scenario
    • 7.7.6.4. Thailand cardiac surgery instruments market, 2021 - 2033 (USD Million)
• 7.8. Latin America
  • 7.8.1. Brazil
    • 7.8.1.1. Key Country Dynamics
    • 7.8.1.2. Regulatory Scenario
    • 7.8.1.3. Competitive Scenario
    • 7.8.1.4. Brazil cardiac surgery instruments market, 2021 - 2033 (USD Million)
  • 7.8.2. Argentina
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Regulatory Scenario
    • 7.8.2.3. Competitive Scenario
    • 7.8.2.4. Argentina cardiac surgery instruments market, 2021 - 2033 (USD Million)
• 7.9. MEA
  • 7.9.1. South Africa
    • 7.9.1.1. Key Country Dynamics
    • 7.9.1.2. Regulatory Scenario
    • 7.9.1.3. Competitive Scenario
    • 7.9.1.4. South Africa cardiac surgery instruments market, 2021 - 2033 (USD Million)
  • 7.9.2. Saudi Arabia
    • 7.9.2.1. Key Country Dynamics
    • 7.9.2.2. Regulatory Scenario
    • 7.9.2.3. Competitive Scenario
    • 7.9.2.4. Saudi Arabia cardiac surgery instruments market, 2021 - 2033 (USD Million)
  • 7.9.3. UAE
    • 7.9.3.1. Key Country Dynamics
    • 7.9.3.2. Regulatory Scenario
    • 7.9.3.3. Competitive Scenario
    • 7.9.3.4. UAE cardiac surgery instruments market, 2021 - 2033 (USD Million)
  • 7.9.4. Kuwait
    • 7.9.4.1. Key Country Dynamics
    • 7.9.4.2. Regulatory Scenario
    • 7.9.4.3. Competitive Scenario
    • 7.9.4.4. Kuwait cardiac surgery instruments market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company Categorization
• 8.3. Company Profiles
  • 8.3.1. B. Braun Melsungen AG
    • 8.3.1.1. Company overview
    • 8.3.1.2. Financial performance
    • 8.3.1.3. Product benchmarking
    • 8.3.1.4. Strategic initiatives
  • 8.3.2. KLS Martin Group.
    • 8.3.2.1. Company overview
    • 8.3.2.2. Financial performance
    • 8.3.2.3. Product benchmarking
    • 8.3.2.4. Strategic initiatives
  • 8.3.3. Teleflex Incorporated
    • 8.3.3.1. Company overview
    • 8.3.3.2. Financial performance
    • 8.3.3.3. Product benchmarking
    • 8.3.3.4. Strategic initiatives
  • 8.3.4. Medline Industries, Inc.
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. STILLE
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Sklar Corporation
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Wexler Surgical
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Murray Surgical
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Surtex Instruments Limited
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Scanlan International
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. Delacroix-Chevailer
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. BD
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Product benchmarking
    • 8.3.12.4. Strategic initiatives